Indolecarbonyl Coupling Reactions Promoted by SmI2
J . Org. Chem., Vol. 63, No. 9, 1998 2915
organic phase was concentrated under reduced pressure
and chromatographed on a silica gel column with elution
of EtOAc/hexane to give products.
) 10.0, 7.6 Hz), 6.20 (1 H, d, J ) 7.6 Hz), 6.88-7.04 (3
H, m), 7.19-7.30 (4 H, m), 7.67 (1 H, d, J ) 7.2 Hz), 7.86
(1 H, d, J ) 8.8 Hz); 13C NMR (CD3CN, 50 MHz) δ 36.8,
41.4, 48.2, 66.4, 81.2, 114.0, 115.6, 118.3, 121.4, 124.0,
125.8, 126.0, 126.3, 127.2, 127.9, 130.0, 130.8, 136.0,
142.8, 175.5; MS m/z (rel intensity) 446 (18, M+), 195 (98),
144 (68), 116 (100), 89 (25); HRMS calcd for C20H18N2O6S2
446.0606, found 446.0598.
1,3,3a,8b-Tetr ah ydr o-1-h ydr oxy-4-(m eth ylsu lfon yl)-
3-[1-(m eth ylsu lfon yl)in dol-3-yl]fu r o[3,4-b]in dole (4b).
According to the general procedure, treatment of 1-(me-
thylsulfonyl)indole-3-carboxaldehyde (1b) with SmI2 gave
the self-coupling product (66%, three isomers (92:6:2)).
The major isomer was isolated by recrystallization and
determined to have the (1R*,3S*,3aS*,8bR*) configura-
tion by an X-ray diffraction analysis: solid; mp 199-200
°C (from CHCl3-cyclohexane); TLC (EtOAc/hexane (1:
3a ,8b -Dih yd r o-4-(m et h ylsu lfon yl)-3-(4-m et h oxy-
p h en yl)fu r o[3,4-b]in d ol-1-on e (23). A mixture of the
(1R*,3R*,3aS*,8bR*) and (1S*,3R*,3aS*,8bR*) isomers
of 7a (17 mg, 0.05 mmol) was treated with PDC (40 mg,
0.10 mmol) and molecular sieves (4 Å, 1 g) in CH2Cl2 (6
mL) at room temperature (25 °C) for 4 h. The mixture
was concentrated and chromatographed on a silica gel
column by elution with EtOAc/hexane (1:3) to give a
lactone (3R*,3aS*,8bR*)-23 (14 mg, 83%): oil; TLC
(EtOAc/hexane (3:7)) Rf ) 0.17; IR (neat) 1781, 1355,
1251, 1164, 754 cm-1; 1H NMR (CDCl3, 200 MHz) δ 2.86
(3 H, s), 3.80 (3 H, s), 4.39 (1 H, d, J ) 9.1 Hz), 4.86 (1 H,
dd, J ) 9.1, 1.7 Hz), 5.87 (1 H, d, J ) 1.7 Hz), 6.94 (2 H,
d, J ) 8.8 Hz), 7.17 (1 H, t, J ) 7.5 Hz), 7.31-7.38 (1 H,
m), 7.36 (2 H, d, J ) 8.8 Hz), 7.46 (1 H, d, J ) 7.5 Hz),
7.56 (1 H, d, J ) 7.5 Hz); 13C NMR (CDCl3, 75 MHz) δ
35.6, 46.0, 55.3, 71.0, 87.0, 114.1, 114.4 (2 C), 125.1, 125.2,
126.0, 126.7 (2 C), 129.5, 130.3, 141.0, 160.0, 173.8; MS
m/z (rel intensity) 359 (31, M+), 315 (3), 280 (11), 236
(19), 195 (100), 144 (26), 116 (64); HRMS calcd for C18H17-
NO5S 359.0827, found 359.0835.
1-(Meth ylsu lfon yl)-2-(3H-in dol-3-yliden e)m eth ylin -
d ole-3-ca r b oxa ld eh yd e (26). Hemiacetal (1R*,3S*,
3aS*,8bR*)-4b (50 mg, 0.11 mmol) was treated with
p-TsOH (21 mg, 0.11 mmol) in refluxing benzene (25 mL)
for 24 h. A Dean-Stark apparatus was equipped for
removal of water. The mixture was cooled, filtered
through a pad of silica gel, and rinsed with EtOAc/hexane
(1:1). The organic phase was concentrated and chro-
matographed on a silica gel column by elution with
EtOAc/hexane (1:4) to give 26 (33 mg, 85%): oil; TLC
(EtOAc/hexane (1:4)) Rf ) 0.10; IR (neat) 2848, 1684,
1363, 1167, 1128 cm-1; 1H NMR (CDCl3, 200 MHz) δ 3.28
(3 H, s), 7.37-7.57 (3 H, m), 7.63 (1 H, s, vinyl H), 7.71-
7.86 (2 H, m), 8.01 (1 H, d, J ) 8.0 Hz), 8.21 (1 H, dd, J
) 8.0, 1.5 Hz), 8.96 (1 H, dd, J ) 8.0, 1.5 Hz), 9.17 (1 H,
s, HCdN), 10.32 (1 H, s, CHO); 13C NMR (CDCl3, 75
MHz) δ 41.4, 113.4, 116.2, 120.2, 123.2, 124.6, 125.3,
126.1, 127.1, 129.1, 129.7, 129.8, 130.1, 130.2, 134.8,
135.2, 148.4, 152.2, 193.2; MS m/z (rel intensity) 350 (35,
M+), 271 (100), 243 (61), 216 (33); HRMS calcd for
C19H14N2O3S 350.0725, found 350.0722.
1)) Rf ) 0.18; IR (neat) 3483, 2928, 1593, 1347, 1158 cm-1
;
1H NMR (CDCl3, 300 MHz) δ 2.52 (3 H, s), 3.06 (3 H, s),
3.26 (1 H, s), 4.26 (1 H, d, J ) 8.5 Hz), 5.07 (1 H, dd, J
) 8.5, 5.7 Hz), 5.70 (1 H, s), 5.80 (1 H, d, J ) 5.7 Hz),
7.06-7.35 (8 H, m), 7.89 (1 H, d, J ) 8.1 Hz); 13C NMR
(CDCl3, 50 MHz) δ 35.8, 40.4, 54.2, 68.4, 77.4, 102.3,
113.0, 115.0, 118.0, 120.9, 123.1, 124.8, 124.9, 125.3,
125.9, 129.2, 130.0 (2 C), 135.1, 142.2; MS m/z (rel
intensity) 448 (10, M+), 224 (64), 146 (59), 118 (100), 79
(6); HRMS calcd for C20H20N2O6S2 448.0763, found,
448.0766. The structure was confirmed by an X-ray
diffraction.
3-Acetyl-2-[1-h yd r oxy-(4-m eth oxyp h en yl)m eth yl]-
1-m eth ylin d ole (11a ). According to the general proce-
dure, treatment of 3-acetyl-1-methylindole-2-carbonitrile
(2b) and p-methoxybenzaldehyde (1:1.5) with SmI2 in the
presence of HMPA gave the indolecarbonyl coupling
product 11a (85%): oil; TLC (EtOAc/hexane (3:7)) Rf )
0.33; IR (neat) 3380, 1607, 1505, 1466, 1172, 972 cm-1
;
1H NMR (CDCl3, 200 MHz) δ 2.70 (3 H, s), 3.72 (3 H, s),
3.73 (3 H, s), 6.25 (1 H, br s), 6.71 (2 H, d, J ) 8.7 Hz),
7.11 (2 H, d, J ) 8.7 Hz), 7.14-7.35 (3 H, m), 7.84-7.89
(1 H, m); 13C NMR (CDCl3, 75 MHz) δ 30.8, 31.5, 55.2,
68.1, 110.5, 113.8 (2 C), 114.4, 120.8, 122.7, 122.8, 126.4,
127.3 (2 C), 133.2, 136.7, 150.7, 159.0, 196.4; MS m/z (rel
intensity) 309 (100, M+), 294 (20), 262 (7), 200 (10), 186
(26), 135 (15); HRMS calcd for C19H19O3N 309.1365, found
309.1363.
2,3-Dih yd r o-1-h yd r oxy-1H-p yr r olo[1,2-a ]in d ole-9-
ca r boxa ld eh yd e (21a ). According to the general pro-
cedure, a solution of 20a (135 mg, 0.67 mmol) in THF (8
mL) was added via syringe pump to the SmI2-HMPA
solution over a period of 30 min to give 21a (86 mg,
64%): solid; mp 113-115 °C; TLC (EtOAc/hexane (7:3))
Rf ) 0.34; IR (KBr) 3351, 1632, 1567, 1428, 1255 cm-1
;
1H NMR (CDCl3, 200 MHz) δ 2.58-2.72 (1 H, m), 2.98-
3.09 (1 H, m), 4.01-4.14 (1 H, m), 4.28-4.39 (1 H, m),
5.59 (1 H, dd, J ) 7.7, 6.2 Hz), 7.23-7.35 (3 H, m), 7.94-
8.00 (1 H, m), 10.08 (1 H, s); 13C NMR (CDCl3, 50 MHz)
δ 36.0, 44.2, 68.1, 110.1, 110.9, 119.5, 123.0, 123.2, 130.5,
132.5, 154.4, 185.0; MS m/z (rel intensity) 201 (100, M+),
184 (22), 172 (14), 154 (15), 145 (20); HRMS calcd for
C12H11O2N 201.0790, found 201.0792.
1,4-Dim et h yl-3-(4-m et h oxyp h en yl)fu r o[3,4-b]in -
d ole (27). By a procedure similar to that for 26,
treatment of 11a (20 mg, 0.065 mmol) with p-TsOH in
refluxing benzene for 5 h gave 27 (15 mg, 82%): oil; TLC
(EtOAc/hexane (3:7)) Rf ) 0.19; IR (neat) 2937, 1608,
1513, 1460, 1263 cm-1; 1H NMR (CDCl3, 300 MHz) δ 2.49
(3 H, s), 3.63 (3 H, s), 3.85 (3 H, s), 6.50 (2 H, dd, J ) 7.0,
2.0 Hz), 6.86 (2 H, dd, J ) 7.0, 2.0 Hz), 7.25-7.38 (3 H,
m), 7.90-7.93 (1 H, m); 13C NMR (CDCl3, 75 MHz) δ 30.7,
30.9, 55.0, 110.5, 113.2 (2 C), 115.6, 120.8, 122.1, 122.4,
126.1, 129.5 (2 C), 129.9, 131.7, 133.9, 136.8, 145.9, 158.7;
MS m/z (rel intensity) 291 (79, M+), 279 (78), 224 (100),
197 (48), 143 (98); HRMS calcd for C19H17O2N 291.1259,
found 291.1252.
3a ,8b-Dih yd r o-4-(m eth ylsu lfon yl)-3-[(1-m eth ylsu l-
fon yl)in d ol-3-yl]fu r o[3,4-b]in d ol-1-on e (22). Hemi-
acetal (1R*,3S*,3aS*,8bR*)-4b (23 mg, 0.05 mmol) was
treated with DDQ (45 mg, 0.2 mmol) in benzene (10 mL)
at room temperature (27 °C) for 16 h. The mixture was
concentrated and chromatographed on a silica gel column
by elution with EtOAc/hexane (1:1) to give lactone (3S*,
3aS*,8bR*)-22 (13 mg, 57%): solid; mp 210-211 °C; TLC
(EtOAc/hexane (2:3)) Rf ) 0.09; IR (neat) 1753, 1361,
1
1158 cm-1; H NMR (CDCl3, 200 MHz) δ 2.64 (3 H, s),
3-(4-Meth oxyph en yl)th ien o[3,4-b]in dole (28). Com-
pound 8a (35 mg, 0.12 mmol) was treated with Lawes-
3.03 (3 H, s), 4.61 (1 H, d, J ) 10.0 Hz), 5.49 (1 H, dd, J